Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 3;13:8783–8794. doi: 10.2147/OTT.S258450

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The level of RIG-I is decreased in human clinical hepatic carcinoma (HCC) patients. (A) Twelve pairs of HCC specimens and its paired paracancerous specimens were collected. The levels of RIG-I were detected by Western blotting analysis. (C) control tissues referred to the paracancerous tissues; (T) tumor tissues, that is the HCC specimens. (B) The levels of RIG-I in noncancerous tissues and HCC tissues were shown in scatter-plot. Beta-actin was used as internal reference gene. **p<0.01, compared with noncancerous tissues. (C) RT-PCR assay. The relative mRNA level of RIG-I was shown in scatter-plot in a cohort of 12 HCC specimens and its paired noncancerous tissues. **p<0.01, compared with noncancerous tissues.